Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan

Abstract Purpose The real-world effectiveness and safety of abiraterone or enzalutamide in the Asian population with metastatic castration-resistant prostate cancer (mCRPC) remains unclear. Methods Using the Taiwan National Health Insurance Research Database, we identified a cohort of 3056 patients...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Wen-Kuan Huang, Po-Jung Su, Chun-Chi Chen, Ching-Fu Chang, Shao-Ming Yu, Ming-Jer Hsieh, Ming-Lung Tsai, Tien-Hsing Chen, Pao-Hsien Chu, I-Chang Hsieh, See-Tong Pang, Dong-Yi Chen
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Springer 2025-10-01
Cyfres:	Journal of Cancer Research and Clinical Oncology
Pynciau:	Metastatic castration-resistant prostate cancer Abiraterone Enzalutamide Survival analysis CV safety
Mynediad Ar-lein:	https://doi.org/10.1007/s00432-025-06335-2
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!